GHUCCTS

About Us

Share This

About GHUCCTS

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is a multi-institutional consortium of medical research institutions forged from a desire to promote clinical research and translational science. The members of the GHUCCTS consortium are: Georgetown University (GU), Howard University (HU), MedStar Health Research Institute (MHRI), Oak Ridge National Laboratory (ORNL), and the Washington Veteran’s Affairs Medical Center (VAMC).

Through multiple partnerships and collaborations among the member institutions, GHUCCTS is transforming clinical research and translational science in order to bring new scientific advances to health care. 

GHUCCTS was founded on five basic principles that have been endorsed by each of the member institutions. These serve to identify the overall purpose of the consortium, as well as key aspects of its research activities, governance, and focus. These principles form the foundation of the consortium itself, as well as the GHUCCTS programs of research and education.


GHUCCTS Founding Principles

  1. The primary goal of GHUCCTS is to improve the infrastructure that supports high quality multidisciplinary clinical and translational research, both via inter-institutional collaborations across all GHUCCTS institutions as well as multicenter clinical trials across the national CTSA consortium, with increasing levels of speed and efficiency, and to develop innovative informatics methods to speed and enhance translation.

  2. We continue to develop GHUCCTS as a model of inter-institutional collaboration that leverages the strengths and attributes of its diverse participating institutions

  3. Leverage our location, expertise and the co-leadership of a minority-serving institution to design and implement research that will have a high impact on underserved populations, including minorities, people with disabilities, and elderly populations.

  4. Design and disseminate vibrant and innovative educational programs at multiple levels (undergraduate, medical school, graduate, study coordinators, research nurses, and junior faculty) that promote team science and provides the highest quality of career development training for the clinical and translational investigators of the future.

  5. Draw from and contribute to the collective effort of the National CTSA consortium to advance GHUCCTS, the National Center for Advancing Translational Science (NCATS), and the CTSA consortium.
Related News

TL1 Scholar Dr. Martha Dee Gay receives Science Writer Fellowship from Georgetown Medicine Magazine

May 15, 2020

2020 Science Writer Fellow Martha Dee Gay is an NIH TL1 post-doctoral scholar and translational scientist at Georgetown University Medical Center in the Division of Gastroenterology. Her article "Life in the NASH Lane" is published in the Spring/Summer 2020 edition of Georgetown Medicine Magazine.

GHUCCTS KL2 Program application deadline extended

May 07, 2020

The GHUCCTS KL2 Program is now accepting applications for the 2019-2020 cycle. Projects that are novel, inter- or multi-disciplinary and collaborative will be favored. The KL2 Scholars will be awarded up to $90,000 salary support and $40,000 project support per year (for up to three years).

NIH awards $23M to GHUCCTS to support clinical and translational research

May 01, 2020

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

Close